FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
What happened?
The risk appears small and data is mixed, but FDA wants patients to be aware.
Story details
The risk appears small and data is mixed, but FDA wants patients to be aware.
Why it matters
This story helps build a stronger internal English tech archive around Technology, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.